Taiyin Y Yang

age ~70

from Monte Sereno, CA

Get Report

Also known as:

Connected to:

Taiyin Yang Phones & Addresses

Method And Composition For Pharmaceutical Product
view source
US Patent:

20070077295, Apr 5, 2007
Filed:

Jun 13, 2006
Appl. No.:

11/452472
Inventors:

Terrence Dahl - Sunnyvale CA, US
Mark Menning - San Francisco CA, US
Reza Oliyai - San Carlos CA, US
Taiyin Yang - Saratoga CA, US
International Classification:

A61K 31/675
A61K 9/20
US Classification:

424464000, 514081000
Abstract:

This invention is directed to a composition comprising dry granulated tenofovir DF and emtricitabine, and a method for making same. Dry granulation was unexpectedly found to be important in preparing a tenofovir DF containing composition suitable for inclusion in a combination dosage form containing emtricitabine, efavirenz and tenofovir DF.

Unitary Pharmaceutical Dosage Form
view source
US Patent:

20070099902, May 3, 2007
Filed:

Jun 13, 2006
Appl. No.:

11/453122
Inventors:

Terrence Dahl - Sunnyvale CA, US
Munir Hussain - Belle Mead NJ, US
Robert Lipper - Pennington NJ, US
Robert Jerzewski - Belle Mead NJ, US
Mark Menning - San Francisco CA, US
Reza Oliyai - San Carlos CA, US
Taiyin Yang - Saratoga CA, US
International Classification:

A61K 31/551
A61K 31/522
A61K 31/513
US Classification:

514221000, 514263320, 514269000
Abstract:

In accordance with this invention a novel pharmaceutical product containing efavirenz, emtricitabine and tenofovir DF are provided as a multicomponent unitary oral dosage form, component 1 comprising tenofovir DF (and, optionally, emtricitabine) and component 2 comprising efavirenz, wherein components 1 and 2 are in a stabilizing configuration. In preferred embodiments component 1 is made by dry granulation.

Unitary Pharmaceutical Dosage Form
view source
US Patent:

20140037724, Feb 6, 2014
Filed:

Oct 10, 2013
Appl. No.:

14/050714
Inventors:

Munir A. Hussain - Belle Mead NJ, US
Robert A. Lipper - Pennington NJ, US
Robert L. Jerzewski - Balle Mead NJ, US
Mark M. Menning - San Francisco CA, US
Reza Oliyai - San Carlos CA, US
Taiyin Yang - Saratoga CA, US
Assignee:

BRISTOL-MYERS SQUIBB & GILEAD SCIENCES, LLC - Foster City CA
International Classification:

A61K 31/683
A61K 31/513
A61K 31/536
US Classification:

424464, 514 81
Abstract:

In accordance with this invention a novel pharmaceutical product containing efavirenz, emtricitabine and tenofovir DF are provided as a multicomponent unitary oral dosage form, component 1 comprising tenofovir DF (and, optionally, emtricitabine) and component 2 comprising efavirenz, wherein components 1 and 2 are in a stabilizing configuration. In preferred embodiments component 1 is made by dry granulation.

Method And Composition For Pharmaceutical Product
view source
US Patent:

20140037732, Feb 6, 2014
Filed:

Jul 29, 2013
Appl. No.:

13/953577
Inventors:

Mark M. Menning - San Francisco CA, US
Reza Oliyai - Burlingame CA, US
Taiyin Yang - Saratoga CA, US
Assignee:

Gilead Sciences, Inc. - Foster CIty CA
International Classification:

A61J 3/00
US Classification:

424489, 514 81
Abstract:

This invention is directed to a composition comprising dry granulated tenofovir DF and emtricitabine, and a method for making same. Dry granulation was unexpectedly found to be important in preparing a tenofovir DF containing composition suitable for inclusion in a combination dosage form containing emtricitabine, efavirenz and tenofovir DF.

Unitary Pharmaceutical Dosage Form
view source
US Patent:

20170079999, Mar 23, 2017
Filed:

Dec 6, 2016
Appl. No.:

15/370588
Inventors:

- Foster City CA, US
Munir A. HUSSAIN - Belle Mead NJ, US
Robert A. LIPPER - Pennington NJ, US
Robert L. JERZEWSKI - Belle Mead NJ, US
Mark M. MENNING - San Francisco CA, US
Reza OLIYAI - Burlingame CA, US
Taiyin YANG - Monte Sereno CA, US
International Classification:

A61K 31/683
Abstract:

In accordance with this invention a novel pharmaceutical product containing efavirenz, emtricitabine and tenofovir DF are provided as a multicomponent unitary oral dosage form, component 1 comprising tenofovir DF (and, optionally, emtricitabine) and component 2 comprising efavirenz, wherein components 1 and 2 are in a stabilizing configuration. In preferred embodiments component 1 is made by dry granulation.

Unitary Pharmaceutical Dosage Form
view source
US Patent:

20150174147, Jun 25, 2015
Filed:

Mar 6, 2015
Appl. No.:

14/640825
Inventors:

- Foster City CA, US
Munir A. HUSSAIN - Belle Mead NJ, US
Robert A. LIPPER - Pennington NJ, US
Robert L. JERZEWSKI - Belle Mead NJ, US
Mark M. MENNING - San Francisco CA, US
Taiyin YANG - Monte Sereno CA, US
International Classification:

A61K 31/683
A61K 31/513
A61K 9/24
A61K 31/536
Abstract:

In accordance with this invention a novel pharmaceutical product containing efavirenz, emtricitabine and tenofovir DF are provided as a multicomponent unitary oral dosage form, component 1 comprising tenofovir DF (and, optionally, emtricitabine) and component 2 comprising efavirenz, wherein components 1 and 2 are in a stabilizing configuration. In preferred embodiments component 1 is made by dry granulation.

Method And Composition For Pharmaceutical Product
view source
US Patent:

20140370102, Dec 18, 2014
Filed:

Aug 29, 2014
Appl. No.:

14/472511
Inventors:

- Foster City CA, US
Mark M. Menning - San Francisco CA, US
Reza Oliyai - Burlingame CA, US
Taiyin Yang - Monte Sereno CA, US
International Classification:

A61K 9/16
A61K 31/513
A61K 31/683
US Classification:

424489, 514 81
Abstract:

This invention is directed to a composition comprising dry granulated tenofovir DF and emtricitabine, and a method for making same. Dry granulation was unexpectedly found to be important in preparing a tenofovir DF containing composition suitable for inclusion in a combination dosage form containing emtricitabine, efavirenz and tenofovir DF.